BOXED WARNING Suicidal thoughts and behaviors — antidepressants increased the risk in children, adolescents, and young adults; monitor closely. FORFIVO XL is not approved for use in pediatric patients.
FDA dosing
Population
Start
Target
Max
Major depressive disorder (MDD)
Adults
Do not initiate with FORFIVO XL; use another bupropion formulation to titrate. Use in patients on 300 mg/day of another bupropion formulation ≥2 weeks who require 450 mg/day
450 mg QD
450 mg/day
Renal Not recommended (no lower dose strength available)
Hepatic Not recommended (no lower dose strength available)
450 mg is the only available strength; do not exceed 450 mg/day and do not initiate therapy with FORFIVO XL.
Instructions
Take one 450 mg tablet once daily, with or without food
Swallow whole; do not chew, divide, or crush
Do not initiate therapy with FORFIVO XL; use another bupropion formulation for titration and for tapering before discontinuation
Allow at least 14 days between MAOI and FORFIVO XL in either direction
Contraindications
Seizure disorder
Current use of other bupropion products
Current or prior diagnosis of bulimia or anorexia nervosa
Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs
Use of MAOIs (intended to treat psychiatric disorders) concomitantly or within 14 days of discontinuing FORFIVO XL, or starting FORFIVO XL in a patient treated with reversible MAOIs such as linezolid or intravenous methylene blue
Cautions
Neuropsychiatric adverse events (in smoking cessation use)
Seizure risk — dose-dependent; discontinue if seizure occurs
Hypertension — assess and monitor blood pressure
Activation of mania/hypomania — screen for bipolar disorder
Pregnancy First-trimester epidemiologic data have not identified an increased overall risk of congenital malformations; weigh against risks of untreated depression.
Lactation Bupropion and metabolites present in human milk (~2% of maternal weight-adjusted dose); seizures reported in breastfed infants.
⚠ BOXED WARNING
Suicidal thoughts and behaviors in patients under 25